| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/12/2004 | WO2002094196A3 Method of treatment for cancers associated with elevated |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002066063A8 Remedies for metabolic bone diseases |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | WO2002053580A3 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 02/12/2004 | WO2002030406A3 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 02/12/2004 | US20040030248 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040029993 E-ptfe foil impregnated with an encapsulated bioative substance |
| 02/12/2004 | US20040029972 Synergistic mixtuyre of antidepressant and serotonine receptor antagonist; psychological disorders; sexual disorders |
| 02/12/2004 | US20040029970 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029953 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029927 Oral administering of tablet of triprolidine |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029917 Benzosuberonylpiperdine compounds as analgesics |
| 02/12/2004 | US20040029912 Bicyclic derivatives |
| 02/12/2004 | US20040029910 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |
| 02/12/2004 | US20040029901 Obesity therapy; administering orlistat |
| 02/12/2004 | US20040029900 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 02/12/2004 | US20040029898 Anticancer agents |
| 02/12/2004 | US20040029895 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 02/12/2004 | US20040029894 Nootropic effect enhancer |
| 02/12/2004 | US20040029891 Use of PDE5 inhibitors in the treatment of polycystic ovary syndrome |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029884 Cyclization in presence of Lawesson's reagent |
| 02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
| 02/12/2004 | US20040029882 Antimicrobial quinolones, their compositions and uses |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029879 Viricides for herpes virus |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029871 Pharmaceutical compounds for treating copd |
| 02/12/2004 | US20040029870 Antiinflammatory agents |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029864 Synergistic mixture of cyclooxygenase inhibitor and active drug |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029860 Anti-proliferative drugs |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029838 Anticancer agents |
| 02/12/2004 | US20040029829 Bean extract; fermentation |
| 02/12/2004 | US20040029828 Homeostasis-maintaining agents |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |
| 02/12/2004 | US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics |
| 02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | US20040029767 Disinfectant |
| 02/12/2004 | US20040029280 Viral vectors with modified tropism |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040028755 Use of CYP2D6 inhibitors in combination therapies |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028727 Dry formulation for transcutaneous immunization |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028691 Administering eicosapentaenoic acid, docosahexaenoic acid |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 02/12/2004 | US20040028643 Compositions for retarding skin aging |
| 02/12/2004 | US20040028626 Photoprotective UV-screening compositions comprising triazine/dibenzoylmethane/diarylbutadiene compounds |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | DE10233229A1 Pharmazeutische Zusammensetzung zur Senkung des Triglyceridspiegels A pharmaceutical composition for lowering triglyceride levels |
| 02/12/2004 | CA2494801A1 Medicinal composition containing hmg-coa reductase inhibitor |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494616A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | CA2494288A1 Novel salt and polymorphs of desloratadine hemifumarate |
| 02/12/2004 | CA2494214A1 Conjugates of porphyrin compounds with chemotherapeutic agents |
| 02/12/2004 | CA2494146A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | CA2493795A1 Method of preparing platelet rich plasma |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |